Our findings demonstrate a significant and robust correlation between ENTPD1 and Hodgkin lymphoma, suggesting that the inhibition of ENTPD1 may also exhibit antitumor effects in this disease. The gene discussed is ENTPD1; the disease is Hodgkins lymphoma.